BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21153520)

  • 1. Complement activation by phospholipids: the interplay of factor H and C1q.
    Tan LA; Yu B; Sim FC; Kishore U; Sim RB
    Protein Cell; 2010 Nov; 1(11):1033-49. PubMed ID: 21153520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
    Tan LA; Yang AC; Kishore U; Sim RB
    Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor H as a regulator of the classical pathway activation.
    Kishore U; Sim RB
    Immunobiology; 2012 Feb; 217(2):162-8. PubMed ID: 21852018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.
    Kang YH; Varghese PM; Aiyan AA; Pondman K; Kishore U; Sim RB
    Front Immunol; 2024; 15():1368852. PubMed ID: 38933264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.
    Hwang HY; Duvall MR; Tomlinson S; Boackle RJ
    Mol Immunol; 2008 May; 45(9):2570-80. PubMed ID: 18313756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.
    Sjöberg A; Onnerfjord P; Mörgelin M; Heinegård D; Blom AM
    J Biol Chem; 2005 Sep; 280(37):32301-8. PubMed ID: 16046396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway.
    Kishore U; Strong P; Perdikoulis MV; Reid KB
    J Immunol; 2001 Jan; 166(1):559-65. PubMed ID: 11123337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
    Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
    Front Immunol; 2020; 11():848. PubMed ID: 32536911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q.
    Vogt LM; Kwasniewicz E; Talens S; Scavenius C; Bielecka E; Ekdahl KN; Enghild JJ; Mörgelin M; Saxne T; Potempa J; Blom AM
    J Immunol; 2020 May; 204(10):2779-2790. PubMed ID: 32253242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme interacts with c1q and inhibits the classical complement pathway.
    Roumenina LT; Radanova M; Atanasov BP; Popov KT; Kaveri SV; Lacroix-Desmazes S; Frémeaux-Bacchi V; Dimitrov JD
    J Biol Chem; 2011 May; 286(18):16459-69. PubMed ID: 21454703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner.
    Bradley AJ; Brooks DE; Norris-Jones R; Devine DV
    Biochim Biophys Acta; 1999 Apr; 1418(1):19-30. PubMed ID: 10209207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
    Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
    Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.
    Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of the classical complement pathway by C1q-binding peptides.
    Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
    J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.
    Mitchell DA; Kirby L; Paulin SM; Villiers CL; Sim RB
    Mol Immunol; 2007 Apr; 44(11):2997-3004. PubMed ID: 17337056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.